<DOC>
	<DOCNO>NCT00921947</DOCNO>
	<brief_summary>1 . To assess safety , reactogenicity , tolerability , adverse event ( AEs ) VAX102 vaccine two dose regimen ( Day 0 Day 28 ) 1.0 µg dose level deliver i.m. , 2.0 µg dose level deliver s.c. healthy adult population . 2 . To assess immunogenicity ( anti-M2e serum antibody concentration ) VAX102 vaccine two dose regimen ( Day 0 Day 28 ) 1.0 µg dose level deliver i.m. , 2.0 µg dose level deliver s.c. measure enzyme-linked immunosorbent assay ( ELISA ) healthy adult population .</brief_summary>
	<brief_title>Comparative Safety Immunogenicity 1.0 µg Intramuscular ( i.m . ) 2.0 µg Subcutaneous ( s.c. ) Dosing With VAX102 ( M2e-flagellin ) Universal Influenza Vaccine Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adult men woman age 18 49 year inclusive . Able willing provide write informed consent participate . Healthy , determine medical history , physical examination , vital sign . Willing receive unlicensed ( VAX102 ) vaccine give i.m . s.c. injection . Willing provide multiple blood specimen collect venipuncture . Females avoid become pregnant course study Women childbearing potential must negative urine pregnancy test within 24 hour precede receipt first precede receipt second ( booster ) vaccination . Must exhibit comprehension study requirement ; express availability require study period expect reside study area entire study period , ability attend schedule visit . Persons 18 year old 50 year old . Persons chronic illness cancer , diabetes , liver kidney disease . Person currently pregnant , nurse mother plan pregnancy within one month vaccination . Persons prior serious reaction influenza vaccine . Persons history anaphylactictype reaction inject vaccine . Persons history drug chemical abuse year precede study . Persons receive influenza vaccine current influenza season plan receive influenza vaccine participate study . Persons receive vaccine within one week prior enrollment ( may delay enrollment ) . Persons respiratory illness illness fever within three day study enrollment ( may delay enrollment ) . Persons currently participate another research study involve study medication ( medicine vaccine ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>M2e</keyword>
	<keyword>Universal influenza vaccine</keyword>
</DOC>